Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition ...

A popular obesity drug may help treat ... the medication in the weight loss drug Zepbound and also the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnea along with ...

A popular weight loss drug may be able to assist in the treatment of sleep apnea, a new study found. Tirzepatide, the medicine found in the drug Zepbound and the obesity drug Mounjaro, reduced the ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound ...

The makers of the weight loss drug tirzepatide ... the results of a Phase 3 study showing that the drug was effective in treating sleep apnea. Eli Lilly said that 10- and 15-milligram injections ...

Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...

Precision medicine and phenotyping help tailor treatments to individual patient profiles.

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...